• Home
  • Scientific Publications
  • News & Press Release
  • News Archive
  • Company
  • Technology and Facility
  • Partners & Investors
  • Our Services (New)
  • In-House Testing Services (New)
  • Contact Us
  • PDPA
Austrianova

Austrianova Secures Significant Investment from Real Tech Fund

by Walter Gunzburg | Jul 7, 2021 | Press Release

SINGAPORE, July 7th, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased and honoured to announce that, after extensive due diligence, Real Tech Fund (managed by Real Tech Holdings, Japan) has invested an undisclosed...

Austrianova Secures $100 Million USD Investment Commitment from GEM as Company Seeks to Go Public

by Walter Gunzburg | Apr 22, 2021 | Press Release

Singapore based Company envisages going public via SPAC merger or traditional IPO SINGAPORE, April 22, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has signed an Agreement with GEM Global...

November 30th, 2020: Complete protection of probiotics from destruction by stomach acid using Bac-in-a-Box technology

by Walter Gunzburg | Nov 30, 2020 | Press Release

Austrianova announced today that a key publication on the ability of its patented technology, Bac-in-a-Box, to completely protect probiotics from acidic conditions found in the stomach has been published in the well respected journal “Microbial Cell Factories”...

28 July 2020: Austrianova files Drug Master File with FDA

by Walter Gunzburg | Jul 28, 2020 | Press Release

S.E. Asian company, Austrianova, headquartered in Singapore, announced today that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA). This DMF provides all confidential and detailed information covering the production of...
Next Entries »
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS
@ 2020 Austrianova Singapore • Bangkok